ONTOLOGY REPORT - ANNOTATIONS
| Term: | tributylstannane |
|
| Accession: | CHEBI:27086
|
browse the term
|
| Definition: | An organotin compound that has formula C12H28Sn. |
| Synonyms: | related_synonym: | C12H28Sn; InChI=1S/3C4H9.Sn.H/c3*1-3-4-2;;/h3*1,3-4H2,2H3;;; InChIKey=DBGVGMSCBYYSLD-UHFFFAOYSA-N; SnBu3H; TBT; Tri-n-butyltin; Tri-n-butyltin hydride; Tributyltin; [H][Sn](CCCC)(CCCC)CCCC; [Sn(Bu)3H] |
| | xref_casrn: | 688-73-3 |
| | xref: | Beilstein:3587329 "Beilstein Registry Number"; ChEBI:c0579 "UM-BBD compID"; ChEMBL:798558 "ChEMBL COMPOUND"; ChemIDplus:688-73-3 "CAS Registry Number"; Gmelin:4258 "Gmelin Registry Number" |
| | xref_mesh: | MESH:C011559 |
| | xref: | NIST Chemistry WebBook:688-73-3 "CAS Registry Number" |
|
|
tributylstannane
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
increases expression |
EXP |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahrr |
aryl-hydrocarbon receptor repressor |
|
multiple interactions |
ISO |
1 |
29,797,025 |
29,894,912 |
RGD:6480464 |
CTD |
| G |
Ahrr |
aryl-hydrocarbon receptor repressor |
|
decreases expression |
ISO |
1 |
29,797,025 |
29,894,912 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
EXP |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
increases expression |
EXP |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
increases expression |
EXP |
4 |
120,889,617 |
120,947,662 |
RGD:6480464 |
CTD |
| G |
Aspn |
asporin |
|
increases expression |
EXP |
17 |
21,035,597 |
21,058,999 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
increases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
increases expression |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
increases activity |
ISO |
14 |
86,632,686 |
86,721,281 |
RGD:6480464 |
CTD |
| G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
|
increases activity |
ISO |
2 |
223,840,650 |
224,108,082 |
RGD:6480464 |
CTD |
| G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
|
increases activity |
ISO |
15 |
3,729,433 |
3,786,060 |
RGD:6480464 |
CTD |
| G |
Car14 |
carbonic anhydrase 14 |
|
increases expression |
EXP |
2 |
190,683,916 |
190,690,229 |
RGD:6480464 |
CTD |
| G |
Car9 |
carbonic anhydrase 9 |
|
increases expression |
EXP |
5 |
59,986,413 |
59,993,015 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Ccdc125 |
coiled-coil domain containing 125 |
|
decreases expression |
EXP |
2 |
31,475,995 |
31,494,913 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
decreases expression |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
increases expression |
ISO |
10 |
87,925,093 |
87,936,325 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 molecule |
|
increases expression |
EXP |
17 |
26,705,646 |
26,725,470 |
RGD:6480464 |
CTD |
| G |
Cdyl |
chromodomain protein, Y-like |
|
increases expression |
EXP |
17 |
35,290,255 |
35,517,646 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
decreases expression |
EXP |
17 |
82,708,354 |
83,025,139 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
decreases activity |
ISO |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
increases expression |
EXP |
13 |
47,139,658 |
47,147,591 |
RGD:6480464 |
CTD |
| G |
Cidec |
cell death-inducing DFFA-like effector c |
|
increases expression |
ISO |
4 |
149,307,986 |
149,321,303 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
increases expression |
EXP |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
increases expression |
EXP |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
multiple interactions |
ISO |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
decreases expression |
ISO |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Cplx3 |
complexin 3 |
|
increases expression |
EXP |
8 |
61,354,177 |
61,360,939 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
decreases expression |
EXP |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
EXP |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crlf1 |
cytokine receptor-like factor 1 |
|
increases expression |
EXP |
16 |
19,431,472 |
19,442,747 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
decreases expression |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dkk3 |
dickkopf 3 homolog (Xenopus laevis) |
|
increases expression |
EXP |
1 |
169,924,617 |
169,964,692 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
decreases expression |
ISO |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dpt |
dermatopontin |
|
increases expression |
EXP |
13 |
80,562,890 |
80,591,361 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
decreases expression |
EXP |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
increases expression |
EXP |
1 |
179,712,404 |
179,754,345 |
RGD:6480464 |
CTD |
| G |
Efemp1 |
EGF-containing fibulin-like extracellular matrix protein 1 |
|
increases expression |
EXP |
14 |
109,733,625 |
109,828,630 |
RGD:6480464 |
CTD |
| G |
Ehd2 |
EH-domain containing 2 |
|
increases expression |
EXP |
1 |
76,292,179 |
76,310,584 |
RGD:6480464 |
CTD |
| G |
Enam |
enamelin |
|
multiple interactions |
ISO |
14 |
21,137,021 |
21,162,644 |
RGD:6480464 |
CTD |
| G |
Enam |
enamelin |
|
decreases expression |
ISO |
14 |
21,137,021 |
21,162,644 |
RGD:6480464 |
CTD |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
increases expression |
EXP |
17 |
34,093,525 |
34,270,498 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fgl2 |
fibrinogen-like 2 |
|
increases expression |
EXP |
4 |
9,176,333 |
9,181,976 |
RGD:6480464 |
CTD |
| G |
Fli1 |
Friend leukemia virus integration 1 |
|
increases expression |
EXP |
8 |
32,187,952 |
32,309,782 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
increases expression |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
EXP |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
increases expression |
EXP |
10 |
106,394,006 |
106,396,171 |
RGD:6480464 |
CTD |
| G |
Gbx2 |
gastrulation brain homeobox 2 |
|
decreases expression |
EXP |
9 |
89,034,340 |
89,037,102 |
RGD:6480464 |
CTD |
| G |
Gda |
guanine deaminase |
|
increases expression |
EXP |
1 |
224,579,794 |
224,655,298 |
RGD:6480464 |
CTD |
| G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
|
increases expression |
EXP |
5 |
25,809,543 |
26,008,249 |
RGD:6480464 |
CTD |
| G |
Gk |
glycerol kinase |
|
increases expression |
ISO |
X |
72,416,872 |
72,493,296 |
RGD:6480464 |
CTD |
| G |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
|
increases expression |
EXP |
4 |
28,847,907 |
28,853,347 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
decreases expression |
EXP |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
increases expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Gria4 |
glutamate receptor, ionotropic, AMPA 4 |
|
increases expression |
EXP |
8 |
956,325 |
1,438,314 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Hat1 |
histone acetyltransferase 1 |
|
increases activity |
EXP |
3 |
53,696,664 |
53,744,333 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases activity |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
increases activity |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
increases expression |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein B8 |
|
increases expression |
EXP |
12 |
41,407,166 |
41,421,565 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
EXP |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
increases expression |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
|
decreases expression |
EXP |
3 |
105,322,270 |
105,341,927 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
increases expression |
EXP |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
increases expression |
EXP |
15 |
49,982,103 |
50,068,902 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Med13 |
mediator complex subunit 13 |
|
increases expression |
EXP |
10 |
74,498,274 |
74,584,128 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
increases expression |
EXP |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Msx1 |
msh homeobox 1 |
|
multiple interactions |
ISO |
14 |
78,257,345 |
78,261,144 |
RGD:6480464 |
CTD |
| G |
Msx1 |
msh homeobox 1 |
|
decreases expression |
ISO |
14 |
78,257,345 |
78,261,144 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
EXP |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
increases expression |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
increases expression |
EXP |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
multiple interactions |
ISO |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases activity |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Olr287 |
olfactory receptor 287 |
|
decreases expression |
EXP |
1 |
200,001,939 |
200,002,869 |
RGD:6480464 |
CTD |
| G |
Otx2 |
orthodenticle homeobox 2 |
|
increases expression |
EXP |
15 |
24,622,851 |
24,632,435 |
RGD:6480464 |
CTD |
| G |
P4ha3 |
prolyl 4-hydroxylase, alpha polypeptide III |
|
increases expression |
EXP |
1 |
157,663,338 |
157,720,713 |
RGD:6480464 |
CTD |
| G |
Phex |
phosphate regulating endopeptidase homolog, X-linked |
|
multiple interactions |
ISO |
X |
58,911,144 |
59,168,857 |
RGD:6480464 |
CTD |
| G |
Plp2 |
proteolipid protein 2 (colonic epithelium-enriched) |
|
increases expression |
EXP |
X |
26,875,110 |
26,878,509 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rab3b |
RAB3B, member RAS oncogene family |
|
increases expression |
EXP |
5 |
130,185,155 |
130,284,038 |
RGD:6480464 |
CTD |
| G |
Rarg |
retinoic acid receptor, gamma |
|
increases expression |
EXP |
7 |
140,991,447 |
141,014,108 |
RGD:6480464 |
CTD |
| G |
RT1-CE5 |
RT1 class I, locus CE5 |
|
increases expression |
EXP |
20 |
3,509,593 |
3,513,732 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
increases expression |
EXP |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
Slc16a3 |
solute carrier family 16, member 3 (monocarboxylic acid transporter 4) |
|
increases expression |
EXP |
10 |
110,159,679 |
110,163,182 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
decreases expression |
ISO |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
multiple interactions |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
multiple interactions |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Spon2 |
spondin 2, extracellular matrix protein |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases activity |
ISO |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
decreases activity |
ISO |
6 |
21,453,521 |
21,489,408 |
RGD:6480464 |
CTD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
increases expression |
EXP |
6 |
21,453,521 |
21,489,408 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srpx2 |
sushi-repeat-containing protein, X-linked 2 |
|
increases expression |
EXP |
X |
121,446,756 |
121,468,691 |
RGD:6480464 |
CTD |
| G |
Sv2b |
synaptic vesicle glycoprotein 2b |
|
increases expression |
EXP |
1 |
130,683,155 |
130,884,752 |
RGD:6480464 |
CTD |
| G |
Syt4 |
synaptotagmin IV |
|
increases expression |
EXP |
18 |
23,805,080 |
23,814,489 |
RGD:6480464 |
CTD |
| G |
Tecpr1 |
tectonin beta-propeller repeat containing 1 |
|
increases expression |
EXP |
12 |
10,719,095 |
10,747,027 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
increases expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
increases expression |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tmem106a |
transmembrane protein 106A |
|
increases expression |
EXP |
10 |
90,602,484 |
90,611,299 |
RGD:6480464 |
CTD |
| G |
Tmod1 |
tropomodulin 1 |
|
increases expression |
EXP |
5 |
62,578,142 |
62,668,760 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
EXP |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trim47 |
tripartite motif-containing 47 |
|
increases expression |
EXP |
10 |
106,211,265 |
106,215,736 |
RGD:6480464 |
CTD |
| G |
Tspo |
translocator protein |
|
increases expression |
EXP |
7 |
121,597,084 |
121,599,342 |
RGD:6480464 |
CTD |
| G |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
|
multiple interactions |
ISO |
6 |
52,605,869 |
52,607,863 |
RGD:6480464 |
CTD |
| G |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
|
decreases expression |
ISO |
6 |
52,605,869 |
52,607,863 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
EXP |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ugt1a5 |
UDP glucuronosyltransferase 1 family, polypeptide A5 |
|
increases expression |
EXP |
9 |
87,052,169 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
increases expression |
EXP |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
| G |
Zfp423 |
zinc finger protein 423 |
|
increases expression |
ISO |
19 |
20,475,864 |
20,739,236 |
RGD:6480464 |
CTD |
Term paths to the root
|